The Impact of Serious Illness on Patients' Families

From the Division of General Medicine and Primary Care and the Division of Clinical Epidemiology, Department of Medicine, Beth Israel Hospital, Boston, Mass; the UCLA School of Medicine, UCLA Medical Center, Los Angeles, Calif; the Marshfield Medical Research Foundation/Marshfield Clinic, Marshfield, Wis; the Duke University Medical Center, Durham, NC; Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio; the Dartmouth-Hitchcock Medical Center, Hanover, NH; and the SUPPORT Coordinating Center, George Washington University, Washington, DC

Kenneth E. Covinsky

2011

Scholarcy highlights

  • From the Division of General Medicine and Primary Care and the Division of Clinical Epidemiology, Department of Medicine, Beth Israel Hospital, Boston, Mass; the UCLA School of Medicine, UCLA Medical Center, Los Angeles, Calif; the Marshfield Medical Research Foundation/Marshfield Clinic, Marshfield, Wis; the Duke University Medical Center, Durham, NC; Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio; the Dartmouth-Hitchcock Medical Center, Hanover, NH; and the SUPPORT Coordinating Center, George Washington University, Washington, DC
  • Objective.—To examine the impact of illness on the families of seriously ill adults and to determine the correlates of adverse economic impact
  • Design.—Data were collected during the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment, a prospective cohort study of outcomes, preferences, and decision making in seriously ill hospitalized adults and their families
  • Participants.—The 2661 seriously ill patients in nine diagnostic categories who survived their index hospitalization and were discharged home were eligible for this analysis
  • Loss of most or all of the family savings was reported by 31% of families, whereas 29% reported loss of the major source of income
  • Patient factors independently associated with loss of the family's savings on multivariable analysis included poor functional status, lower family income, and young age
  • FDA Approval and Regulation of Pharmaceuticals, 1983-2018 Global Burden of Cancer, 1990-2017 Global Burden of Skin Diseases, 1990-2017 Global Firearm Mortality, 1990-2016 Health Care Spending in the US and Other High-Income Countries Life Expectancy and Mortality Rates in the United States, 1959-2017 Medical Marketing in the United States, 1997-2016 Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter President Obama on US Health Care Reform The State of US Health, 1990-2016 US Burden of Cardiovascular Disease, 1990-2016 US Burden of Neurological Disease, 1990-2017 Waste in the US Health Care System: Estimated Costs and Potential for Savings

Need more features? Save interactive summary cards to your Scholarcy Library.